Cargando…
Doxycycline as an Alternative to Azithromycin in Elderly Patients
Autores principales: | Malek, Alexandre Elias, Granwehr, Bruno P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779281/ https://www.ncbi.nlm.nih.gov/pubmed/33408018 http://dx.doi.org/10.1016/j.ijantimicag.2020.106168 |
Ejemplares similares
-
Doxycycline as a potential partner of COVID-19 therapies
por: Malek, Alexandre E., et al.
Publicado: (2020) -
Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021) -
Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients
por: Lacout, Alexis, et al.
Publicado: (2021) -
Malaria Prophylaxis Failure with Doxycycline, Central African Republic, 2014
por: Madamet, Marylin, et al.
Publicado: (2015) -
Azithromycin in patients with COVID-19: Friend or foe?
por: Kow, Chia Siang, et al.
Publicado: (2021)